Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.4 USD | +1.96% | +9.35% | +24.93% |
03-14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
03-13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.93% | 408M | |
-2.47% | 88.14B | |
+3.29% | 40.44B | |
-15.38% | 32.24B | |
+51.96% | 24.39B | |
-14.15% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.56% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Anika Therapeutics : UBS Starts Anika Therapeutics at Neutral With $46 Price Target